| Serial Number | 97441959 |
| Word Mark | DECISION MEDICINE |
| Filing Date | Friday, June 3, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, July 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 13, 2023 |
| Goods and Services | Downloadable software for the collection, management, and analysis of data acquired through nucleic acid sequencing, including next-generation sequencing (NGS), to inform healthcare decisions; downloadable software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for analyzing biological samples; downloadable software for analyzing biological samples for medical purposes, namely, for the screening, diagnosing, treating, and monitoring for recurrence of cancer and other diseases; downloadable software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable software for health and wellness assessment, namely, for use in genomic analysis; downloadable software for genetic and bioinformatics analysis; downloadable software for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics; downloadable software for bioinformatics analysis of information derived through NGS; downloadable software for discovering and monitoring indicators of disease through analysis of sequencing data; downloadable software for detecting the presence and prevalence of cancer molecules and molecules indicative of other diseases through analysis of sequencing data; downloadable software for selecting appropriate therapies for disease treatment and management; downloadable software for developing companion diagnostics (CDx) for disease treatment and management |
| Goods and Services | Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of sequencing data to detect the presence and prevalence of cancer molecules and molecules indicative of other diseases; management services, namely, management of business information and insights learned through analysis of the information relating to therapeutic medicine marketability |
| Goods and Services | Providing localized nucleic acid sequencing for more actionable data to inform healthcare decisions; providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the screening, diagnosing, treating, and monitoring for recurrence of cancer and other diseases; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of diagnostics; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical purposes, health and wellness assessment services; providing health and wellness information; medical services, namely, diagnostic testing for the presence of cancer molecules and molecules indicative of other diseases in bodily fluids; diagnostic testing relating to human health; medical testing services relating to the screening, diagnosing, treating, and monitoring for recurrence of disease; selecting therapies for disease treatment and management; developing companion diagnostics (CDx) for disease treatment and management; management services, namely, management of medical information learned through nucleic acid sequencing, including next-generation sequencing (NGS), and information gathered through analysis of the medical information |
| NOT AVAILABLE | "MEDICINE" |
| Goods and Services | Software as a service (SaaS), namely, hosting non-downloadable software for use by others for collecting, managing, and analyzing data acquired through nucleic acid sequencing, including next-generation sequencing (NGS), to inform healthcare decisions; SaaS, namely, hosting non-downloadable software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, diagnostic research, and diagnostics; SaaS, namely, hosting non-downloadable software for use by others for analyzing biological samples; SaaS, namely, hosting non-downloadable software for use by others for analyzing biological samples for medical purposes, namely, for the screening, diagnosing, treating, and monitoring for recurrence of cancer and other diseases; SaaS, namely, hosting non-downloadable software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; SaaS, namely, hosting non-downloadable software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; SaaS, namely, hosting non-downloadable software for health and wellness assessment, namely, for genomic analysis; SaaS, namely, hosting non-downloadable software for genetic and bioinformatics analysis; SaaS, namely, hosting non-downloadable software for selecting appropriate therapies for disease treatment and management; SaaS, namely, hosting non-downloadable software for developing companion diagnostics (CDx) for disease treatment and management; bioinformatics services, namely, product research and development in the field of bioinformatics; data processing services for medical, clinical, and scientific purposes; developing diagnostic testing models for others for medical, clinical, and scientific purposes; genetic testing for scientific research purposes; scientific consulting relating to scientific research; scientific services, namely, detection and analysis of cancer molecules and molecules indicative of other diseases in bodily fluids; scientific, clinical, and diagnostic research in the field of bioinformatics; scientific, clinical, and diagnostic research in the fields of disease detection and management; scientific, clinical, and diagnostic research in the fields of cancer discovery, cancer management, and therapy efficacy |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 13, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 13, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 13, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 13, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pillar Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Natick, MA 01760 |
| Party Name | Pillar Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Natick, MA 01760 |
| Event Date | Event Description |
| Tuesday, June 7, 2022 | NEW APPLICATION ENTERED |
| Wednesday, November 9, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, June 13, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 26, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, November 9, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 9, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, May 9, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 9, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 9, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 24, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 13, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 13, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 8, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 1, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 1, 2024 | SOU EXTENSION 1 FILED |
| Thursday, February 1, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 30, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 30, 2024 | SOU EXTENSION 2 FILED |
| Saturday, February 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |